1. Home
  2. PROK vs WFF Comparison

PROK vs WFF Comparison

Compare PROK & WFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • WFF
  • Stock Information
  • Founded
  • PROK 2015
  • WFF 1984
  • Country
  • PROK United States
  • WFF Malaysia
  • Employees
  • PROK N/A
  • WFF N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • WFF Miscellaneous manufacturing industries
  • Sector
  • PROK Health Care
  • WFF Consumer Discretionary
  • Exchange
  • PROK Nasdaq
  • WFF Nasdaq
  • Market Cap
  • PROK 94.9M
  • WFF 89.8M
  • IPO Year
  • PROK N/A
  • WFF 2025
  • Fundamental
  • Price
  • PROK $0.81
  • WFF $4.78
  • Analyst Decision
  • PROK Buy
  • WFF
  • Analyst Count
  • PROK 4
  • WFF 0
  • Target Price
  • PROK $5.00
  • WFF N/A
  • AVG Volume (30 Days)
  • PROK 796.9K
  • WFF 18.0K
  • Earning Date
  • PROK 05-12-2025
  • WFF 01-01-0001
  • Dividend Yield
  • PROK N/A
  • WFF N/A
  • EPS Growth
  • PROK N/A
  • WFF N/A
  • EPS
  • PROK N/A
  • WFF 0.00
  • Revenue
  • PROK $306,000.00
  • WFF $4,572,290.00
  • Revenue This Year
  • PROK N/A
  • WFF N/A
  • Revenue Next Year
  • PROK N/A
  • WFF N/A
  • P/E Ratio
  • PROK N/A
  • WFF $1,061.89
  • Revenue Growth
  • PROK N/A
  • WFF N/A
  • 52 Week Low
  • PROK $0.46
  • WFF $3.20
  • 52 Week High
  • PROK $4.44
  • WFF $5.52
  • Technical
  • Relative Strength Index (RSI)
  • PROK 49.17
  • WFF N/A
  • Support Level
  • PROK $0.94
  • WFF N/A
  • Resistance Level
  • PROK $0.87
  • WFF N/A
  • Average True Range (ATR)
  • PROK 0.11
  • WFF 0.00
  • MACD
  • PROK 0.01
  • WFF 0.00
  • Stochastic Oscillator
  • PROK 39.10
  • WFF 0.00

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.

Share on Social Networks: